- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Thyroid Research
Volume 2012 (2012), Article ID 815079, 7 pages
Proteomic Profiling of Thyroid Papillary Carcinoma
1Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan
2Department of Oral Pathology and Diagnosis, School of Dentistry, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
3Ban Thyroid Clinic, 2-11-16 Jiyugaoka, Megro-ku, Tokyo 152-0035, Japan
4Division of Endocrine Surgery, Department of Surgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan
5Biosys Technologies, Inc., 2-13-18 Nakane, Meguro-ku, Tokyo 152-0031, Japan
6Comprehensive Research Center of Oral Cancer, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
Received 12 October 2011; Accepted 6 November 2011
Academic Editor: Fausto Bogazzi
Copyright © 2012 Yoshiyuki Ban et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. A. Hundahl, I. D. Fleming, A. M. Fremgen, and H. R. Menck, “A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995,” Cancer, vol. 83, no. 12, pp. 2638–2648, 1998.
- J. M. Gasent Blesa, E. Grande Pulido, M. Provencio Pulla, et al., “Old and new insights in the treatment of thyroid carcinoma,” Journal of Thyroid Research, vol. 2010, Article ID 279468, 16 pages, 2010.
- J. A. Fagin, “Genetic basis of endocrine disease 3: molecular defects in thyroid gland neoplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 6, pp. 1398–1400, 1992.
- E. T. Kimura, M. N. Nikiforova, Z. Zhu, J. A. Knauf, Y. E. Nikiforov, and J. A. Fagin, “High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma,” Cancer Research, vol. 63, no. 7, pp. 1454–1457, 2003.
- J. A. Fagin, “Challenging dogma in thyroid cancer molecular genetics—role of RET/PTC and BRAF in tumor initiation,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4264–4266, 2004.
- C. Mazzanti, M. A. Zeiger, N. Costourous et al., “Using Gene Expression Profiling to Differentiate Benign versus Malignant Thyroid Tumors,” Cancer Research, vol. 64, no. 8, pp. 2898–2903, 2004.
- D. J. Finley, N. Arora, B. Zhu, L. Gallagher, and T. J. Fahey, “Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3214–3223, 2004.
- J. M. Cerutti, R. Delcelo, M. J. Amadei et al., “A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression,” Journal of Clinical Investigation, vol. 113, no. 8, pp. 1234–1242, 2004.
- B. R. Haugen and M. W. Duncan, “Applications of proteomics to thyroid neoplasms: are we there yet?” Thyroid, vol. 20, no. 10, pp. 1051–1052, 2010.
- T. Kawamura, M. Nomura, H. Tojo et al., “Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) Stage-related protein candidates upon non-metastatic lung adenocarcinoma,” Journal of Proteomics, vol. 73, no. 6, pp. 1089–1099, 2010.
- B. Zybailov, M. K. Coleman, L. Florens, and M. P. Washburn, “Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling,” Analytical Chemistry, vol. 77, no. 19, pp. 6218–6224, 2005.
- M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke, “Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors,” Endocrine Reviews, vol. 28, no. 3, pp. 322–338, 2007.
- N. Morimura, Y. Tezuka, N. Watanabe et al., “Molecular cloning of NPNT: a novel adhesion molecule that interacts with α8β integrin,” The Journal of Biological Chemistry, vol. 276, no. 45, pp. 42172–42181, 2001.
- R. Brandenberger, A. Schmidt, J. Linton et al., “Identification and characterization of a novel extracellular matrix protein nephronectin that is associated with integrin α8β1 in the embryonic kidney,” Journal of Cell Biology, vol. 154, no. 2, pp. 447–458, 2001.
- B. L. Eckhardt, B. S. Parker, R. K. van Laar et al., “Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix,” Molecular Cancer Research, vol. 3, no. 1, pp. 1–13, 2005.
- T. Schallus, C. Jaeckh, K. Fehér et al., “Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation,” Molecular Biology of the Cell, vol. 19, no. 8, pp. 3404–3414, 2008.
- L. N. Muller, C. Muhle-Goll, and M. B. Biskup, “The Glc2Man2-fragment of the N-glycan precursor—a novel ligand for the glycan-binding protein malectin?” Organic and Biomolecular Chemistry, vol. 8, no. 14, pp. 3294–3299, 2010.
- T. Schallus, K. Feher, U. Sternberg, V. Rybin, and C. Muhle-Goll, “Analysis of the specific interactions between the lectin domain of malectin and diglucosides,” Glycobiology, vol. 20, no. 8, pp. 1010–1020, 2010.
- M. Aebi, R. Bernasconi, S. Clerc, and M. Molinari, “N-glycan structures: recognition and processing in the ER,” Trends in Biochemical Sciences, vol. 35, no. 2, pp. 74–82, 2010.
- G. Z. Lederkremer, “Glycoprotein folding, quality control and ER-associated degradation,” Current Opinion in Structural Biology, vol. 19, no. 5, pp. 515–523, 2009.
- C. Galli, R. Bernasconi, T. Soldà, V. Calanca, and M. Molinari, “Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER,” PLoS ONE, vol. 6, no. 1, article e16304, 2011.